Cargando…
Impact of a standardized referral to a community pharmacist-led smoking cessation program before elective joint replacement surgery
INTRODUCTION: Smokers undergoing total joint replacement (TJR) are more likely to develop infections and be re-admitted than non-smokers. The primary purpose of this study was to evaluate the effectiveness of standardized preoperative referral to a community-based pharmacist-led smoking cessation pr...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Publishing on behalf of the International Society for the Prevention of Tobacco Induced Diseases (ISPTID)
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751968/ https://www.ncbi.nlm.nih.gov/pubmed/31582925 http://dx.doi.org/10.18332/tid/101600 |
_version_ | 1783452714793959424 |
---|---|
author | Beaupre, Lauren A. Hammal, Fadi DeSutter, Chrisopher Stiegelmar, Robert E. Masson, Edward Finegan, Barry A. |
author_facet | Beaupre, Lauren A. Hammal, Fadi DeSutter, Chrisopher Stiegelmar, Robert E. Masson, Edward Finegan, Barry A. |
author_sort | Beaupre, Lauren A. |
collection | PubMed |
description | INTRODUCTION: Smokers undergoing total joint replacement (TJR) are more likely to develop infections and be re-admitted than non-smokers. The primary purpose of this study was to evaluate the effectiveness of standardized preoperative referral to a community-based pharmacist-led smoking cessation program compared to usual care for patients undergoing TJR. Secondarily, we evaluated the use of the smoking cessation program. METHODS: A pre-post quasi-experimental study was conducted at a central intake clinic that prepares approximately 3000 TJR patients annually. Participants were recruited at a mean of 13±11.1 weeks preoperatively and provided informed consent. Participants in the ‘pre’ observational phase (OP) received usual care for smoking cessation. For ‘post’ intervention phase (IP) participants, a referral was sent to a community-based pharmacist-led smoking cessation program. Smoking status was validated on study entry using exhaled carbon monoxide. Participants’ smoking status was re-assessed using self-reported point prevalence abstinence at 6 months post-recruitment. RESULTS: We enrolled 120/150 (80%) potential OP candidates and 104/286 (36%) potential IP candidates. The groups were similar on study entry; overall, the mean age of participants was 58.7±9.1 years and 103 (47%) were male. They reported medium nicotine dependence with 37±11.6 mean years smoked. At 6 months post-recruitment, 8 (7%) OP participants self-reported 30-day point prevalence abstinence compared to 21 (20%) IP participants (p=0.003). Only 58 (56%) IP participants complied with the pharmacist referral, with 19 (33%) of those seeing the pharmacist reporting point prevalence abstinence at 6 months compared to only 2 (4%) of the 45 participants who did not see the pharmacist (p<0.001). CONCLUSIONS: Referral to a community smoking cessation program as preoperative standard of care is feasible and can enhance long-term quit rates, but voluntary participation led to low recruitment to the program. |
format | Online Article Text |
id | pubmed-6751968 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | European Publishing on behalf of the International Society for the Prevention of Tobacco Induced Diseases (ISPTID) |
record_format | MEDLINE/PubMed |
spelling | pubmed-67519682019-10-03 Impact of a standardized referral to a community pharmacist-led smoking cessation program before elective joint replacement surgery Beaupre, Lauren A. Hammal, Fadi DeSutter, Chrisopher Stiegelmar, Robert E. Masson, Edward Finegan, Barry A. Tob Induc Dis Research Paper INTRODUCTION: Smokers undergoing total joint replacement (TJR) are more likely to develop infections and be re-admitted than non-smokers. The primary purpose of this study was to evaluate the effectiveness of standardized preoperative referral to a community-based pharmacist-led smoking cessation program compared to usual care for patients undergoing TJR. Secondarily, we evaluated the use of the smoking cessation program. METHODS: A pre-post quasi-experimental study was conducted at a central intake clinic that prepares approximately 3000 TJR patients annually. Participants were recruited at a mean of 13±11.1 weeks preoperatively and provided informed consent. Participants in the ‘pre’ observational phase (OP) received usual care for smoking cessation. For ‘post’ intervention phase (IP) participants, a referral was sent to a community-based pharmacist-led smoking cessation program. Smoking status was validated on study entry using exhaled carbon monoxide. Participants’ smoking status was re-assessed using self-reported point prevalence abstinence at 6 months post-recruitment. RESULTS: We enrolled 120/150 (80%) potential OP candidates and 104/286 (36%) potential IP candidates. The groups were similar on study entry; overall, the mean age of participants was 58.7±9.1 years and 103 (47%) were male. They reported medium nicotine dependence with 37±11.6 mean years smoked. At 6 months post-recruitment, 8 (7%) OP participants self-reported 30-day point prevalence abstinence compared to 21 (20%) IP participants (p=0.003). Only 58 (56%) IP participants complied with the pharmacist referral, with 19 (33%) of those seeing the pharmacist reporting point prevalence abstinence at 6 months compared to only 2 (4%) of the 45 participants who did not see the pharmacist (p<0.001). CONCLUSIONS: Referral to a community smoking cessation program as preoperative standard of care is feasible and can enhance long-term quit rates, but voluntary participation led to low recruitment to the program. European Publishing on behalf of the International Society for the Prevention of Tobacco Induced Diseases (ISPTID) 2019-02-22 /pmc/articles/PMC6751968/ /pubmed/31582925 http://dx.doi.org/10.18332/tid/101600 Text en © 2019 Beaupre L. A https://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License. |
spellingShingle | Research Paper Beaupre, Lauren A. Hammal, Fadi DeSutter, Chrisopher Stiegelmar, Robert E. Masson, Edward Finegan, Barry A. Impact of a standardized referral to a community pharmacist-led smoking cessation program before elective joint replacement surgery |
title | Impact of a standardized referral to a community pharmacist-led smoking cessation program before elective joint replacement surgery |
title_full | Impact of a standardized referral to a community pharmacist-led smoking cessation program before elective joint replacement surgery |
title_fullStr | Impact of a standardized referral to a community pharmacist-led smoking cessation program before elective joint replacement surgery |
title_full_unstemmed | Impact of a standardized referral to a community pharmacist-led smoking cessation program before elective joint replacement surgery |
title_short | Impact of a standardized referral to a community pharmacist-led smoking cessation program before elective joint replacement surgery |
title_sort | impact of a standardized referral to a community pharmacist-led smoking cessation program before elective joint replacement surgery |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751968/ https://www.ncbi.nlm.nih.gov/pubmed/31582925 http://dx.doi.org/10.18332/tid/101600 |
work_keys_str_mv | AT beauprelaurena impactofastandardizedreferraltoacommunitypharmacistledsmokingcessationprogrambeforeelectivejointreplacementsurgery AT hammalfadi impactofastandardizedreferraltoacommunitypharmacistledsmokingcessationprogrambeforeelectivejointreplacementsurgery AT desutterchrisopher impactofastandardizedreferraltoacommunitypharmacistledsmokingcessationprogrambeforeelectivejointreplacementsurgery AT stiegelmarroberte impactofastandardizedreferraltoacommunitypharmacistledsmokingcessationprogrambeforeelectivejointreplacementsurgery AT massonedward impactofastandardizedreferraltoacommunitypharmacistledsmokingcessationprogrambeforeelectivejointreplacementsurgery AT fineganbarrya impactofastandardizedreferraltoacommunitypharmacistledsmokingcessationprogrambeforeelectivejointreplacementsurgery |